Norges Bank Allakos Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$5.08 - $9.81 $1.42 Million - $2.74 Million
-279,155 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$8.55 - $111.89 $2.39 Million - $31.2 Million
279,155 New
279,155 $2.73 Million
Q3 2021

Nov 14, 2022
BUY
$76.53 - $110.43 $19.9 Million - $28.8 Million
260,442 New
260,442 $27.6 Million
Q3 2021

Nov 05, 2021
SELL
$76.53 - $110.43 $14.4 Million - $20.8 Million
-188,389 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$85.37 - $114.1 $16.1 Million - $21.5 Million
188,389 New
188,389 $16.1 Million
Q2 2021

Aug 10, 2021
SELL
$85.37 - $114.1 $11.5 Million - $15.3 Million
-134,225 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$109.73 - $153.66 $14.7 Million - $20.6 Million
134,225 New
134,225 $15.4 Million
Q1 2021

May 07, 2021
SELL
$109.73 - $153.66 $31.1 Million - $43.6 Million
-283,701 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$79.58 - $152.45 $22.6 Million - $43.3 Million
283,701 New
283,701 $39.7 Million
Q4 2020

Feb 10, 2021
SELL
$79.58 - $152.45 $23.4 Million - $44.7 Million
-293,519 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$66.43 - $90.99 $19.5 Million - $26.7 Million
293,519 New
293,519 $23.9 Million
Q3 2020

Nov 10, 2020
SELL
$66.43 - $90.99 $20.4 Million - $27.9 Million
-306,952 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$44.04 - $80.69 $13.5 Million - $24.8 Million
306,952 New
306,952 $22.1 Million
Q2 2020

Aug 07, 2020
SELL
$44.04 - $80.69 $8.14 Million - $14.9 Million
-184,770 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$44.49 - $93.39 $8.22 Million - $17.3 Million
184,770 New
184,770 $8.22 Million
Q4 2019

Feb 12, 2020
SELL
$66.49 - $137.73 $1.33 Million - $2.75 Million
-20,000 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$31.0 - $89.73 $620,000 - $1.79 Million
20,000 New
20,000 $1.57 Million
Q3 2019

Nov 08, 2019
SELL
$31.0 - $89.73 $620,000 - $1.79 Million
-20,000 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$36.0 - $44.73 $720,000 - $894,599
20,000 New
20,000 $867,000
Q2 2019

Aug 09, 2019
SELL
$36.0 - $44.73 $720,000 - $894,599
-20,000 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$31.59 - $62.65 $631,800 - $1.25 Million
20,000 New
20,000 $1.05 Million
Q4 2018

Feb 08, 2019
SELL
$31.59 - $62.65 $631,800 - $1.25 Million
-20,000 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$31.25 - $47.64 $625,000 - $952,800
20,000 New
20,000 $900,000

Others Institutions Holding ALLK

# of Institutions
82
Shares Held
64.7M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $82.2M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email